conv.

All stories
HealthQuiet · 34h

Supreme Court calls cancer drug pricing 'broad daylight dacoity' as markups hit 10x cost

Indian justices express shock over essential medicine sold at ₹27,000 despite ₹2,700 retailer cost, questioning silent authorities.

newest coverage 1d agosummary written 1d ago8 pieces Google NewsNewswires

What to know

  • Supreme Court condemned a 10-fold markup on an essential cancer drug (₹27,000 MRP vs. ₹2,700 retailer cost) as 'extortion' and 'broad daylight dacoity.'
  • The court expressed shock that regulatory authorities responsible for enforcing price controls under the Drugs (Prices Control) Order, 2013, have taken no action.
  • Petitions before the court seek strict price control enforcement and disciplinary measures against medical practitioners who fail to prescribe generic medicines.
  • The government, represented by the Additional Solicitor General, signaled willingness to address the issue without adversarial positioning.

“It is very surprising that the authorities who are supposed to take action on this are silent.”

Bench of Justices Vikram Nath and Sandeep Mehta, Supreme Court judges · The Hindu ↗

Bench of Justices Vikram Nath and Sandeep Mehta Supreme Court judges hearing drug pricing petitionsK.M. Nataraj Additional Solicitor General appearing for the CentrePetitioners Filed pleas on drug price controls and generic medicine prescription

Supreme Court calls cancer drug pricing 'broad daylight dacoity' as markups hit 10x cost
The Hindu

How it unfolded 1 development · click the chart to see its coverage articles

Peak 6 pieces in one hour at Sep 22, 7 AM; 8 pieces over 41 hours (8 articles) Sep 22, 7 AM — 6 pieces · 6 articles — Google News 6Sep 22, 8 AM — quietSep 22, 9 AM — quietSep 22, 10 AM — quietSep 22, 11 AM — quietSep 22, 12 PM — quietSep 22, 1 PM — 2 pieces · 2 articles — Newswires 2Sep 22, 2 PM — quietSep 22, 3 PM — quietSep 22, 4 PM — quietSep 22, 5 PM — quietSep 22, 6 PM — quietSep 22, 7 PM — quietSep 22, 8 PM — quietSep 22, 9 PM — quietSep 22, 10 PM — quietSep 22, 11 PM — quietYesterday, 12 AM — quietYesterday, 1 AM — quietYesterday, 2 AM — quietYesterday, 3 AM — quietYesterday, 4 AM — quietYesterday, 5 AM — quietYesterday, 6 AM — quietYesterday, 7 AM — quietYesterday, 8 AM — quietYesterday, 9 AM — quietYesterday, 10 AM — quietYesterday, 11 AM — quietYesterday, 12 PM — quietYesterday, 1 PM — quietYesterday, 2 PM — quietYesterday, 3 PM — quietYesterday, 4 PM — quietYesterday, 5 PM — quietYesterday, 6 PM — quietYesterday, 7 PM — quietYesterday, 8 PM — quietYesterday, 9 PM — quietYesterday, 10 PM — quietYesterday, 11 PM — quiet 1
8 AM4 PMyesterday8 AM4 PMnow · 12:58 AM ET
  1. 1

    Court declares pricing practice 'absolute rampage,' criticizes regulatory inaction

    The Bench called the pricing structure 'absolute rampage and carnage' and noted that patients often sell assets to afford treatment. The court expressed particular frustration that authorities mandated to act have remained silent.

    “This is absolute rampage and carnage. This is broad daylight dacoity with patients. It is very surprising that the authorities who are supposed to take action on this are silent.”
    — Bench of Justices Vikram Nath and Sandeep Mehta
  2. background

    Supreme Court condemns cancer drug overpricing during hearing on drug price controls — A Bench of Justices Vikram Nath and Sandeep Mehta heard two petitions on drug-related issues and expressed shock over the 10-fold markup on an essential cancer medicine, with MRP set at ₹27,000 despite retailers receiving it for ₹2,700.

Also covered reported alongside — the timeline has no entry for these yet

  1. 5 outlets ₹2,700 cancer medicine sold for ₹27,000: Supreme Court flags "broad daylight dacoity" of patients

    first by Bar and Bench, 1d ago · also The Times of India, NDTV, Telegraph India, The Hindu

    4 more headlines

and 1 smaller piece